Samil PharmaceuticalLtd Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 1/6
Samil PharmaceuticalLtd has a total shareholder equity of ₩174.4B and total debt of ₩140.5B, which brings its debt-to-equity ratio to 80.6%. Its total assets and total liabilities are ₩379.5B and ₩205.1B respectively. Samil PharmaceuticalLtd's EBIT is ₩6.3B making its interest coverage ratio 2.4. It has cash and short-term investments of ₩2.0B.
Anahtar bilgiler
80.6%
Borç/özkaynak oranı
₩140.53b
Borç
| Faiz karşılama oranı | 2.4x |
| Nakit | ₩2.01b |
| Eşitlik | ₩174.36b |
| Toplam yükümlülükler | ₩205.10b |
| Toplam varlıklar | ₩379.46b |
Son finansal sağlık güncellemeleri
We Think Samil PharmaceuticalLtd (KRX:000520) Is Taking Some Risk With Its Debt
Sep 11
Does Samil PharmaceuticalLtd (KRX:000520) Have A Healthy Balance Sheet?
May 24Here's Why Samil PharmaceuticalLtd (KRX:000520) Has A Meaningful Debt Burden
Apr 01Recent updates
Optimistic Investors Push Samil Pharmaceutical Co.,Ltd (KRX:000520) Shares Up 29% But Growth Is Lacking
Sep 13We Think Samil PharmaceuticalLtd (KRX:000520) Is Taking Some Risk With Its Debt
Sep 11Investor Optimism Abounds Samil Pharmaceutical Co.,Ltd (KRX:000520) But Growth Is Lacking
Jul 29Does Samil PharmaceuticalLtd (KRX:000520) Have A Healthy Balance Sheet?
May 24There's Reason For Concern Over Samil Pharmaceutical Co.,Ltd's (KRX:000520) Massive 29% Price Jump
Mar 30Samil PharmaceuticalLtd's (KRX:000520) Earnings Are Of Questionable Quality
Mar 21Here's Why Samil PharmaceuticalLtd (KRX:000520) Has A Meaningful Debt Burden
Apr 01Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 141% Total Return On Their Investment
Mar 11Are Dividend Investors Getting More Than They Bargained For With Samil Pharmaceutical Co.,Ltd's (KRX:000520) Dividend?
Feb 15
Should You Be Concerned About Samil Pharmaceutical Co.,Ltd's (KRX:000520) ROE?
Jan 20Why It Might Not Make Sense To Buy Samil Pharmaceutical Co.,Ltd (KRX:000520) For Its Upcoming Dividend
Dec 24Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 221% Total Return On Their Investment
Dec 09What Is The Ownership Structure Like For Samil Pharmaceutical Co.,Ltd (KRX:000520)?
Nov 18Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: A000520's short term assets (₩84.7B) do not cover its short term liabilities (₩114.3B).
Uzun Vadeli Yükümlülükler: A000520's short term assets (₩84.7B) do not cover its long term liabilities (₩90.8B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: A000520's net debt to equity ratio (79.4%) is considered high.
Borcun Azaltılması: A000520's debt to equity ratio has reduced from 112.5% to 80.6% over the past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: A000520 has less than a year of cash runway based on its current free cash flow.
Tahmini Nakit Akışı: A000520 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 26.4% each year